Arrowhead Pharmaceuticals, Inc. (LON:0HI3)

Longboard Pharmaceuticals Revenue

Arrowhead Pharmaceuticals had revenue of $542.71M USD in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $545.21M, up 1,436.97% year-over-year. In the fiscal year ending September 30, 2024, Arrowhead Pharmaceuticals had annual revenue of $3.55M, down -98.52%.

• Revenue (ttm): $545.21M
• Revenue Growth: +1,436.97%
• P/S Ratio: 4.00
• Revenue / Employee: $895.25K
• Employees: 609
• Market Cap: 1.69B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	3.55M	-237.18M	-98.52%
Sep 30, 2023	240.74M	-2.50M	-1.03%
Sep 30, 2022	243.23M	104.94M	75.89%
Sep 30, 2021	138.29M	50.30M	57.16%
Sep 30, 2020	87.99M	-80.80M	-47.87%